| 1 | SLC6A2, TACR1
|
| Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.
|
| Arapulisamy O, Mannangatti P, Jayanthi LD.
|
| J Biol Chem 288(40):28599-610. doi: 10.1074/jbc.M113.472878. Epub 2013 Aug 26.
2013
|
| 2 | SLC6A2, SLC6A3
|
| Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
|
| Guptaroy B, Fraser R, Desai A, Zhang M, Gnegy ME.
|
| Mol Pharmacol 79(3):520-32. Epub 2010 Dec 13.
2011
|
| 3 | SCAMP2, SCAMP5, SLC6A2, SLC6A3, SLC6A4
|
| Modulation of the dopamine transporter by interaction with Secretory Carrier Membrane Protein 2.
|
| Fjorback AW, Müller HK, Haase J, Raarup MK, Wiborg O.
|
| Biochem Biophys Res Commun 406(2):165-70. Epub 2011 Feb 3.
2011
|
| 4 | SLC6A2
|
| Dependence of serotonergic and other nonadrenergic enteric neurons on norepinephrine transporter expression.
|
| Li Z, Caron MG, Blakely RD, Margolis KG, Gershon MD.
|
| J Neurosci 30(49):16730-40.
2010
|
| 5 | SLC6A2, SLC6A3
|
| Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.
|
| Sogawa C, Mitsuhata C, Kumagai-Morioka K, Sogawa N, Ohyama K, Morita K, Kozai K, Dohi T, Kitayama S.
|
| PLoS One 5(8):e11945.
2010
|
| 6 | MECP2, SLC6A2, SMARCA2
|
| Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.
|
| Harikrishnan KN, Bayles R, Ciccotosto GD, Maxwell S, Cappai R, Pelka GJ, Tam PP, Christodoulou J, El-Osta A.
|
| J Neurosci 30(4):1494-501.
2010
|
| 7 | SLC6A2
|
| Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
|
| Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ.
|
| Neuropharmacology 57(7-8):694-701. Epub 2009 Aug 19.
2009
|
| 8 | SLC6A2
|
| A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
|
| Ramoz N, Boni C, Downing AM, Close SL, Peters SL, Prokop AM, Allen AJ, Hamon M, Purper-Ouakil D, Gorwood P.
|
| Neuropsychopharmacology 34(9):2135-42. Epub 2009 Apr 22.
2009
|
| 9 | SLC6A2
|
| Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis.
|
| Hu YF, Caron MG, Sieber-Blum M.
|
| BMC Genomics 10:151.
2009
|
| 10 | SLC6A2
|
| Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
|
| Kim CH, Waldman ID, Blakely RD, Kim KS.
|
| Ann N Y Acad Sci 1129:256-60. Review.
2008
|
| 11 | SLC6A2
|
| Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.
|
| Zhao Z, Baros AM, Zhang HT, Lapiz MD, Bondi CO, Morilak DA, O'Donnell JM.
|
| Neuropsychopharmacology 33(13):3190-200. Epub 2008 Apr 16.
2008
|
| 12 | MAOA, SLC6A2
|
| An interaction between the norepinephrine transporter and monoamine oxidase A polymorphisms, and novelty-seeking personality traits in Korean females.
|
| Lee BC, Yang JW, Lee SH, Kim SH, Joe SH, Jung IK, Choi IG, Ham BJ.
|
| Prog Neuropsychopharmacol Biol Psychiatry 32(1):238-42. Epub 2007 Aug 22.
2008
|
| 13 | SLC6A2, SNAI2, SCRT1, SCRT2
|
| A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
|
| Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS.
|
| Proc Natl Acad Sci U S A 103(50):19164-9. Epub 2006 Dec 4. 2006
|
| 14 | SLC6A2
|
| A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
|
| Hahn MK, Robertson D, Blakely RD.
|
| J Neurosci 23(11):4470-8. 2003
|
| 15 | SLC6A2
|
| Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening.
|
| Stober G, et al.
|
| Am J Med Genet 88(2):158-63. 1999
|
| 16 | SLC6A2
|
| The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons.
|
| Pörzgen P, Bönisch H, Hammermann R, Brüss M.
|
| Biochim Biophys Acta 1398(3):365-70.
1998
|
| 17 | SLC6A2
|
| Systematic search for variation in the human norepinephrine transporter gene : identification of five naturally occurring missense mutations and study of association with major psychiatric disorders.
|
| Stber G, et al.
|
| Am J Med Genet 67 : 523-532. 1996
|
| 18 | SLC6A2
|
| Molecular cloning and organization of the coding region of the human norepinephrine transporter gene.
|
| Przgen P, et al.
|
| Biochem Biophys Res Commun 215 : 1145-1150. 1995
|
| 19 | SLC6A2
|
| Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16.
|
| Gelernter J, et al.
|
| Genomics 18 : 690-692. 1993
|
| 20 | MDRE, ABCB1, ABCB4, SLC5A1, SLC5A2, SLC6A1, SLC6A2, SLC6A4, SLC6A6, SLC6A8, SLC6A9
|
| Molecular characterization of neurotransmitter transporters.
|
| Shafqat S, et al.
|
| Mol Endocrinol 7 : 1517-1529. 1993
|
| 21 | SLC6A4, SLC6A2
|
| Linkage mapping of norepinephrine transporter protein and serotonin transporter protein genes.
|
| Gelernter J, et al.
|
| Am J Hum Genet 53 : 1003. 1993
|